A course of therapeutic radiation to the chest

Current RMA Instruments:

Consolidated RH SOP	120 of 2015 as amended by 21 of 2017
Balance of Probabilities SOP	121 of 2015

Changes from previous Instruments:

ICD Coding:

ICD-9-CM Codes: 150
ICD-10-AM Codes: C15

Brief description

This is a primary cancer of the food pipe that connects the throat and the stomach.

Confirming the diagnosis

Diagnosis requires confirmation by histology, usually based on a biopsy performed via endoscopy. This will also provide information on the cancer type (adenocarcinoma, squamous carcinoma or other) which is needed to apply some of the SOP factors.

The relevant medical specialist is a gastroenterologist, general surgeon or oncologist.

Additional diagnoses covered by SOP

Adeno-, adenosquamous-, squamous-, poorly differentiated- and undifferentiated-carcinoma of the oesophagus;
Adenoid cystic-, oat cell-, polypoid- and psuedosarcomatous- carcinoma of the oesophagus;
Barrett's adenocarcinoma;
Carcinoma of the oesophagus;
Malignant melanoma of the oesophagus;

Conditions not covered by SOP

Carcinoid tumour of the oesophagus^#
Hodgkin's lymphoma* of the oesophagus
Non-Hodgkin's lymphoma* of the oesophagus
Soft tissue sarcoma* of the oesophagus
Secondary/metastatic cancer/carcinoma involving the oesophagus (code to primary cancer site)

* another SOP applies - the SOP has the same name unless otherwise specified

^# non-SOP condition

Clinical onset

Clinical onset will typically coincide with date of diagnosis. The presence of prior upper gastrointestinal symptoms may not provide a basis for establishing a clinical onset, as a range of other conditions could be responsible. Where other conditions have been excluded then more specific symptoms such as difficulty in swallowing may allow a backdating of clinical onset to a time prior to diagnosis.

Clinical worsening

The only SOP worsening factor is for inability to obtain appropriate clinical management. This condition typically has a poor prognosis. Potential treatments (e.g. surgery) can have high risks and seriously impact quality of life. Treatment with palliative rather than curative intent may be appropriate. Establishing worsening due to inability to obtain appropriate clinical management will require expert medical opinion.

Source URL: https://clik.dva.gov.au/ccps-medical-research-library/statements-principles/m/malignant-neoplasm-oesophagus-b033-c15/rulebase-malignant-neoplasm-oesophagus/course-therapeutic-radiation-chest

Achalasia

Current RMA Instruments:

Consolidated RH SOP	120 of 2015 as amended by 21 of 2017
Balance of Probabilities SOP	121 of 2015

Changes from previous Instruments:

ICD Coding:

ICD-9-CM Codes: 150
ICD-10-AM Codes: C15

Brief description

This is a primary cancer of the food pipe that connects the throat and the stomach.

Confirming the diagnosis

Diagnosis requires confirmation by histology, usually based on a biopsy performed via endoscopy. This will also provide information on the cancer type (adenocarcinoma, squamous carcinoma or other) which is needed to apply some of the SOP factors.

The relevant medical specialist is a gastroenterologist, general surgeon or oncologist.

Additional diagnoses covered by SOP

Adeno-, adenosquamous-, squamous-, poorly differentiated- and undifferentiated-carcinoma of the oesophagus;
Adenoid cystic-, oat cell-, polypoid- and psuedosarcomatous- carcinoma of the oesophagus;
Barrett's adenocarcinoma;
Carcinoma of the oesophagus;
Malignant melanoma of the oesophagus;

Conditions not covered by SOP

Carcinoid tumour of the oesophagus^#
Hodgkin's lymphoma* of the oesophagus
Non-Hodgkin's lymphoma* of the oesophagus
Soft tissue sarcoma* of the oesophagus
Secondary/metastatic cancer/carcinoma involving the oesophagus (code to primary cancer site)

* another SOP applies - the SOP has the same name unless otherwise specified

^# non-SOP condition

Clinical onset

Clinical onset will typically coincide with date of diagnosis. The presence of prior upper gastrointestinal symptoms may not provide a basis for establishing a clinical onset, as a range of other conditions could be responsible. Where other conditions have been excluded then more specific symptoms such as difficulty in swallowing may allow a backdating of clinical onset to a time prior to diagnosis.

Clinical worsening

The only SOP worsening factor is for inability to obtain appropriate clinical management. This condition typically has a poor prognosis. Potential treatments (e.g. surgery) can have high risks and seriously impact quality of life. Treatment with palliative rather than curative intent may be appropriate. Establishing worsening due to inability to obtain appropriate clinical management will require expert medical opinion.

Source URL: https://clik.dva.gov.au/ccps-medical-research-library/statements-principles/m/malignant-neoplasm-oesophagus-b033-c15/rulebase-malignant-neoplasm-oesophagus/achalasia

Acute erosive oesophagitis as the result of alkali ingestion

Current RMA Instruments:

Consolidated RH SOP	120 of 2015 as amended by 21 of 2017
Balance of Probabilities SOP	121 of 2015

Changes from previous Instruments:

ICD Coding:

ICD-9-CM Codes: 150
ICD-10-AM Codes: C15

Brief description

This is a primary cancer of the food pipe that connects the throat and the stomach.

Confirming the diagnosis

Diagnosis requires confirmation by histology, usually based on a biopsy performed via endoscopy. This will also provide information on the cancer type (adenocarcinoma, squamous carcinoma or other) which is needed to apply some of the SOP factors.

The relevant medical specialist is a gastroenterologist, general surgeon or oncologist.

Additional diagnoses covered by SOP

Adeno-, adenosquamous-, squamous-, poorly differentiated- and undifferentiated-carcinoma of the oesophagus;
Adenoid cystic-, oat cell-, polypoid- and psuedosarcomatous- carcinoma of the oesophagus;
Barrett's adenocarcinoma;
Carcinoma of the oesophagus;
Malignant melanoma of the oesophagus;

Conditions not covered by SOP

Carcinoid tumour of the oesophagus^#
Hodgkin's lymphoma* of the oesophagus
Non-Hodgkin's lymphoma* of the oesophagus
Soft tissue sarcoma* of the oesophagus
Secondary/metastatic cancer/carcinoma involving the oesophagus (code to primary cancer site)

* another SOP applies - the SOP has the same name unless otherwise specified

^# non-SOP condition

Clinical onset

Clinical onset will typically coincide with date of diagnosis. The presence of prior upper gastrointestinal symptoms may not provide a basis for establishing a clinical onset, as a range of other conditions could be responsible. Where other conditions have been excluded then more specific symptoms such as difficulty in swallowing may allow a backdating of clinical onset to a time prior to diagnosis.

Clinical worsening

The only SOP worsening factor is for inability to obtain appropriate clinical management. This condition typically has a poor prognosis. Potential treatments (e.g. surgery) can have high risks and seriously impact quality of life. Treatment with palliative rather than curative intent may be appropriate. Establishing worsening due to inability to obtain appropriate clinical management will require expert medical opinion.

Source URL: https://clik.dva.gov.au/ccps-medical-research-library/statements-principles/m/malignant-neoplasm-oesophagus-b033-c15/rulebase-malignant-neoplasm-oesophagus/acute-erosive-oesophagitis-result-alkali-ingestion

Alcohol consumption

Current RMA Instruments:

Consolidated RH SOP	120 of 2015 as amended by 21 of 2017
Balance of Probabilities SOP	121 of 2015

Changes from previous Instruments:

ICD Coding:

ICD-9-CM Codes: 150
ICD-10-AM Codes: C15

Brief description

This is a primary cancer of the food pipe that connects the throat and the stomach.

Confirming the diagnosis

Diagnosis requires confirmation by histology, usually based on a biopsy performed via endoscopy. This will also provide information on the cancer type (adenocarcinoma, squamous carcinoma or other) which is needed to apply some of the SOP factors.

The relevant medical specialist is a gastroenterologist, general surgeon or oncologist.

Additional diagnoses covered by SOP

Adeno-, adenosquamous-, squamous-, poorly differentiated- and undifferentiated-carcinoma of the oesophagus;
Adenoid cystic-, oat cell-, polypoid- and psuedosarcomatous- carcinoma of the oesophagus;
Barrett's adenocarcinoma;
Carcinoma of the oesophagus;
Malignant melanoma of the oesophagus;

Conditions not covered by SOP

Carcinoid tumour of the oesophagus^#
Hodgkin's lymphoma* of the oesophagus
Non-Hodgkin's lymphoma* of the oesophagus
Soft tissue sarcoma* of the oesophagus
Secondary/metastatic cancer/carcinoma involving the oesophagus (code to primary cancer site)

* another SOP applies - the SOP has the same name unless otherwise specified

^# non-SOP condition

Clinical onset

Clinical onset will typically coincide with date of diagnosis. The presence of prior upper gastrointestinal symptoms may not provide a basis for establishing a clinical onset, as a range of other conditions could be responsible. Where other conditions have been excluded then more specific symptoms such as difficulty in swallowing may allow a backdating of clinical onset to a time prior to diagnosis.

Clinical worsening

The only SOP worsening factor is for inability to obtain appropriate clinical management. This condition typically has a poor prognosis. Potential treatments (e.g. surgery) can have high risks and seriously impact quality of life. Treatment with palliative rather than curative intent may be appropriate. Establishing worsening due to inability to obtain appropriate clinical management will require expert medical opinion.

Source URL: https://clik.dva.gov.au/ccps-medical-research-library/statements-principles/m/malignant-neoplasm-oesophagus-b033-c15/rulebase-malignant-neoplasm-oesophagus/alcohol-consumption

Being obese

Current RMA Instruments:

Consolidated RH SOP	120 of 2015 as amended by 21 of 2017
Balance of Probabilities SOP	121 of 2015

Changes from previous Instruments:

ICD Coding:

ICD-9-CM Codes: 150
ICD-10-AM Codes: C15

Brief description

This is a primary cancer of the food pipe that connects the throat and the stomach.

Confirming the diagnosis

Diagnosis requires confirmation by histology, usually based on a biopsy performed via endoscopy. This will also provide information on the cancer type (adenocarcinoma, squamous carcinoma or other) which is needed to apply some of the SOP factors.

The relevant medical specialist is a gastroenterologist, general surgeon or oncologist.

Additional diagnoses covered by SOP

Adeno-, adenosquamous-, squamous-, poorly differentiated- and undifferentiated-carcinoma of the oesophagus;
Adenoid cystic-, oat cell-, polypoid- and psuedosarcomatous- carcinoma of the oesophagus;
Barrett's adenocarcinoma;
Carcinoma of the oesophagus;
Malignant melanoma of the oesophagus;

Conditions not covered by SOP

Carcinoid tumour of the oesophagus^#
Hodgkin's lymphoma* of the oesophagus
Non-Hodgkin's lymphoma* of the oesophagus
Soft tissue sarcoma* of the oesophagus
Secondary/metastatic cancer/carcinoma involving the oesophagus (code to primary cancer site)

* another SOP applies - the SOP has the same name unless otherwise specified

^# non-SOP condition

Clinical onset

Clinical onset will typically coincide with date of diagnosis. The presence of prior upper gastrointestinal symptoms may not provide a basis for establishing a clinical onset, as a range of other conditions could be responsible. Where other conditions have been excluded then more specific symptoms such as difficulty in swallowing may allow a backdating of clinical onset to a time prior to diagnosis.

Clinical worsening

The only SOP worsening factor is for inability to obtain appropriate clinical management. This condition typically has a poor prognosis. Potential treatments (e.g. surgery) can have high risks and seriously impact quality of life. Treatment with palliative rather than curative intent may be appropriate. Establishing worsening due to inability to obtain appropriate clinical management will require expert medical opinion.

Source URL: https://clik.dva.gov.au/ccps-medical-research-library/statements-principles/m/malignant-neoplasm-oesophagus-b033-c15/rulebase-malignant-neoplasm-oesophagus/being-obese

Cigar smoking

Current RMA Instruments:

Consolidated RH SOP	120 of 2015 as amended by 21 of 2017
Balance of Probabilities SOP	121 of 2015

Changes from previous Instruments:

ICD Coding:

ICD-9-CM Codes: 150
ICD-10-AM Codes: C15

Brief description

This is a primary cancer of the food pipe that connects the throat and the stomach.

Confirming the diagnosis

Diagnosis requires confirmation by histology, usually based on a biopsy performed via endoscopy. This will also provide information on the cancer type (adenocarcinoma, squamous carcinoma or other) which is needed to apply some of the SOP factors.

The relevant medical specialist is a gastroenterologist, general surgeon or oncologist.

Additional diagnoses covered by SOP

Adeno-, adenosquamous-, squamous-, poorly differentiated- and undifferentiated-carcinoma of the oesophagus;
Adenoid cystic-, oat cell-, polypoid- and psuedosarcomatous- carcinoma of the oesophagus;
Barrett's adenocarcinoma;
Carcinoma of the oesophagus;
Malignant melanoma of the oesophagus;

Conditions not covered by SOP

Carcinoid tumour of the oesophagus^#
Hodgkin's lymphoma* of the oesophagus
Non-Hodgkin's lymphoma* of the oesophagus
Soft tissue sarcoma* of the oesophagus
Secondary/metastatic cancer/carcinoma involving the oesophagus (code to primary cancer site)

* another SOP applies - the SOP has the same name unless otherwise specified

^# non-SOP condition

Clinical onset

Clinical onset will typically coincide with date of diagnosis. The presence of prior upper gastrointestinal symptoms may not provide a basis for establishing a clinical onset, as a range of other conditions could be responsible. Where other conditions have been excluded then more specific symptoms such as difficulty in swallowing may allow a backdating of clinical onset to a time prior to diagnosis.

Clinical worsening

The only SOP worsening factor is for inability to obtain appropriate clinical management. This condition typically has a poor prognosis. Potential treatments (e.g. surgery) can have high risks and seriously impact quality of life. Treatment with palliative rather than curative intent may be appropriate. Establishing worsening due to inability to obtain appropriate clinical management will require expert medical opinion.

Source URL: https://clik.dva.gov.au/ccps-medical-research-library/statements-principles/m/malignant-neoplasm-oesophagus-b033-c15/rulebase-malignant-neoplasm-oesophagus/cigar-smoking

Cigarette smoking

Current RMA Instruments:

Consolidated RH SOP	120 of 2015 as amended by 21 of 2017
Balance of Probabilities SOP	121 of 2015

Changes from previous Instruments:

ICD Coding:

ICD-9-CM Codes: 150
ICD-10-AM Codes: C15

Brief description

This is a primary cancer of the food pipe that connects the throat and the stomach.

Confirming the diagnosis

Diagnosis requires confirmation by histology, usually based on a biopsy performed via endoscopy. This will also provide information on the cancer type (adenocarcinoma, squamous carcinoma or other) which is needed to apply some of the SOP factors.

The relevant medical specialist is a gastroenterologist, general surgeon or oncologist.

Additional diagnoses covered by SOP

Adeno-, adenosquamous-, squamous-, poorly differentiated- and undifferentiated-carcinoma of the oesophagus;
Adenoid cystic-, oat cell-, polypoid- and psuedosarcomatous- carcinoma of the oesophagus;
Barrett's adenocarcinoma;
Carcinoma of the oesophagus;
Malignant melanoma of the oesophagus;

Conditions not covered by SOP

Carcinoid tumour of the oesophagus^#
Hodgkin's lymphoma* of the oesophagus
Non-Hodgkin's lymphoma* of the oesophagus
Soft tissue sarcoma* of the oesophagus
Secondary/metastatic cancer/carcinoma involving the oesophagus (code to primary cancer site)

* another SOP applies - the SOP has the same name unless otherwise specified

^# non-SOP condition

Clinical onset

Clinical onset will typically coincide with date of diagnosis. The presence of prior upper gastrointestinal symptoms may not provide a basis for establishing a clinical onset, as a range of other conditions could be responsible. Where other conditions have been excluded then more specific symptoms such as difficulty in swallowing may allow a backdating of clinical onset to a time prior to diagnosis.

Clinical worsening

The only SOP worsening factor is for inability to obtain appropriate clinical management. This condition typically has a poor prognosis. Potential treatments (e.g. surgery) can have high risks and seriously impact quality of life. Treatment with palliative rather than curative intent may be appropriate. Establishing worsening due to inability to obtain appropriate clinical management will require expert medical opinion.

Source URL: https://clik.dva.gov.au/ccps-medical-research-library/statements-principles/m/malignant-neoplasm-oesophagus-b033-c15/rulebase-malignant-neoplasm-oesophagus/cigarette-smoking

Consuming insufficient fruit and vegetables

Current RMA Instruments:

Consolidated RH SOP	120 of 2015 as amended by 21 of 2017
Balance of Probabilities SOP	121 of 2015

Changes from previous Instruments:

ICD Coding:

ICD-9-CM Codes: 150
ICD-10-AM Codes: C15

Brief description

This is a primary cancer of the food pipe that connects the throat and the stomach.

Confirming the diagnosis

Diagnosis requires confirmation by histology, usually based on a biopsy performed via endoscopy. This will also provide information on the cancer type (adenocarcinoma, squamous carcinoma or other) which is needed to apply some of the SOP factors.

The relevant medical specialist is a gastroenterologist, general surgeon or oncologist.

Additional diagnoses covered by SOP

Adeno-, adenosquamous-, squamous-, poorly differentiated- and undifferentiated-carcinoma of the oesophagus;
Adenoid cystic-, oat cell-, polypoid- and psuedosarcomatous- carcinoma of the oesophagus;
Barrett's adenocarcinoma;
Carcinoma of the oesophagus;
Malignant melanoma of the oesophagus;

Conditions not covered by SOP

Carcinoid tumour of the oesophagus^#
Hodgkin's lymphoma* of the oesophagus
Non-Hodgkin's lymphoma* of the oesophagus
Soft tissue sarcoma* of the oesophagus
Secondary/metastatic cancer/carcinoma involving the oesophagus (code to primary cancer site)

* another SOP applies - the SOP has the same name unless otherwise specified

^# non-SOP condition

Clinical onset

Clinical onset will typically coincide with date of diagnosis. The presence of prior upper gastrointestinal symptoms may not provide a basis for establishing a clinical onset, as a range of other conditions could be responsible. Where other conditions have been excluded then more specific symptoms such as difficulty in swallowing may allow a backdating of clinical onset to a time prior to diagnosis.

Clinical worsening

The only SOP worsening factor is for inability to obtain appropriate clinical management. This condition typically has a poor prognosis. Potential treatments (e.g. surgery) can have high risks and seriously impact quality of life. Treatment with palliative rather than curative intent may be appropriate. Establishing worsening due to inability to obtain appropriate clinical management will require expert medical opinion.

Source URL: https://clik.dva.gov.au/ccps-medical-research-library/statements-principles/m/malignant-neoplasm-oesophagus-b033-c15/rulebase-malignant-neoplasm-oesophagus/consuming-insufficient-fruit-and-vegetables

Drinking maté

Current RMA Instruments:

Consolidated RH SOP	120 of 2015 as amended by 21 of 2017
Balance of Probabilities SOP	121 of 2015

Changes from previous Instruments:

ICD Coding:

ICD-9-CM Codes: 150
ICD-10-AM Codes: C15

Brief description

This is a primary cancer of the food pipe that connects the throat and the stomach.

Confirming the diagnosis

Diagnosis requires confirmation by histology, usually based on a biopsy performed via endoscopy. This will also provide information on the cancer type (adenocarcinoma, squamous carcinoma or other) which is needed to apply some of the SOP factors.

The relevant medical specialist is a gastroenterologist, general surgeon or oncologist.

Additional diagnoses covered by SOP

Adeno-, adenosquamous-, squamous-, poorly differentiated- and undifferentiated-carcinoma of the oesophagus;
Adenoid cystic-, oat cell-, polypoid- and psuedosarcomatous- carcinoma of the oesophagus;
Barrett's adenocarcinoma;
Carcinoma of the oesophagus;
Malignant melanoma of the oesophagus;

Conditions not covered by SOP

Carcinoid tumour of the oesophagus^#
Hodgkin's lymphoma* of the oesophagus
Non-Hodgkin's lymphoma* of the oesophagus
Soft tissue sarcoma* of the oesophagus
Secondary/metastatic cancer/carcinoma involving the oesophagus (code to primary cancer site)

* another SOP applies - the SOP has the same name unless otherwise specified

^# non-SOP condition

Clinical onset

Clinical onset will typically coincide with date of diagnosis. The presence of prior upper gastrointestinal symptoms may not provide a basis for establishing a clinical onset, as a range of other conditions could be responsible. Where other conditions have been excluded then more specific symptoms such as difficulty in swallowing may allow a backdating of clinical onset to a time prior to diagnosis.

Clinical worsening

The only SOP worsening factor is for inability to obtain appropriate clinical management. This condition typically has a poor prognosis. Potential treatments (e.g. surgery) can have high risks and seriously impact quality of life. Treatment with palliative rather than curative intent may be appropriate. Establishing worsening due to inability to obtain appropriate clinical management will require expert medical opinion.

Source URL: https://clik.dva.gov.au/ccps-medical-research-library/statements-principles/m/malignant-neoplasm-oesophagus-b033-c15/rulebase-malignant-neoplasm-oesophagus/drinking-mat

Gastro-oesophageal reflux disease

Current RMA Instruments:

Consolidated RH SOP	120 of 2015 as amended by 21 of 2017
Balance of Probabilities SOP	121 of 2015

Changes from previous Instruments:

ICD Coding:

ICD-9-CM Codes: 150
ICD-10-AM Codes: C15

Brief description

This is a primary cancer of the food pipe that connects the throat and the stomach.

Confirming the diagnosis

Diagnosis requires confirmation by histology, usually based on a biopsy performed via endoscopy. This will also provide information on the cancer type (adenocarcinoma, squamous carcinoma or other) which is needed to apply some of the SOP factors.

The relevant medical specialist is a gastroenterologist, general surgeon or oncologist.

Additional diagnoses covered by SOP

Adeno-, adenosquamous-, squamous-, poorly differentiated- and undifferentiated-carcinoma of the oesophagus;
Adenoid cystic-, oat cell-, polypoid- and psuedosarcomatous- carcinoma of the oesophagus;
Barrett's adenocarcinoma;
Carcinoma of the oesophagus;
Malignant melanoma of the oesophagus;

Conditions not covered by SOP

Carcinoid tumour of the oesophagus^#
Hodgkin's lymphoma* of the oesophagus
Non-Hodgkin's lymphoma* of the oesophagus
Soft tissue sarcoma* of the oesophagus
Secondary/metastatic cancer/carcinoma involving the oesophagus (code to primary cancer site)

* another SOP applies - the SOP has the same name unless otherwise specified

^# non-SOP condition

Clinical onset

Clinical onset will typically coincide with date of diagnosis. The presence of prior upper gastrointestinal symptoms may not provide a basis for establishing a clinical onset, as a range of other conditions could be responsible. Where other conditions have been excluded then more specific symptoms such as difficulty in swallowing may allow a backdating of clinical onset to a time prior to diagnosis.

Clinical worsening

The only SOP worsening factor is for inability to obtain appropriate clinical management. This condition typically has a poor prognosis. Potential treatments (e.g. surgery) can have high risks and seriously impact quality of life. Treatment with palliative rather than curative intent may be appropriate. Establishing worsening due to inability to obtain appropriate clinical management will require expert medical opinion.

Source URL: https://clik.dva.gov.au/ccps-medical-research-library/statements-principles/m/malignant-neoplasm-oesophagus-b033-c15/rulebase-malignant-neoplasm-oesophagus/gastro-oesophageal-reflux-disease

No appropriate clinical management for malignant neoplasm of oesophagus

Current RMA Instruments:

Consolidated RH SOP	120 of 2015 as amended by 21 of 2017
Balance of Probabilities SOP	121 of 2015

Changes from previous Instruments:

ICD Coding:

ICD-9-CM Codes: 150
ICD-10-AM Codes: C15

Brief description

This is a primary cancer of the food pipe that connects the throat and the stomach.

Confirming the diagnosis

Diagnosis requires confirmation by histology, usually based on a biopsy performed via endoscopy. This will also provide information on the cancer type (adenocarcinoma, squamous carcinoma or other) which is needed to apply some of the SOP factors.

The relevant medical specialist is a gastroenterologist, general surgeon or oncologist.

Additional diagnoses covered by SOP

Adeno-, adenosquamous-, squamous-, poorly differentiated- and undifferentiated-carcinoma of the oesophagus;
Adenoid cystic-, oat cell-, polypoid- and psuedosarcomatous- carcinoma of the oesophagus;
Barrett's adenocarcinoma;
Carcinoma of the oesophagus;
Malignant melanoma of the oesophagus;

Conditions not covered by SOP

Carcinoid tumour of the oesophagus^#
Hodgkin's lymphoma* of the oesophagus
Non-Hodgkin's lymphoma* of the oesophagus
Soft tissue sarcoma* of the oesophagus
Secondary/metastatic cancer/carcinoma involving the oesophagus (code to primary cancer site)

* another SOP applies - the SOP has the same name unless otherwise specified

^# non-SOP condition

Clinical onset

Clinical onset will typically coincide with date of diagnosis. The presence of prior upper gastrointestinal symptoms may not provide a basis for establishing a clinical onset, as a range of other conditions could be responsible. Where other conditions have been excluded then more specific symptoms such as difficulty in swallowing may allow a backdating of clinical onset to a time prior to diagnosis.

Clinical worsening

The only SOP worsening factor is for inability to obtain appropriate clinical management. This condition typically has a poor prognosis. Potential treatments (e.g. surgery) can have high risks and seriously impact quality of life. Treatment with palliative rather than curative intent may be appropriate. Establishing worsening due to inability to obtain appropriate clinical management will require expert medical opinion.

Source URL: https://clik.dva.gov.au/ccps-medical-research-library/statements-principles/m/malignant-neoplasm-oesophagus-b033-c15/rulebase-malignant-neoplasm-oesophagus/no-appropriate-clinical-management-malignant-neoplasm-oesophagus

Pernicious anaemia

Current RMA Instruments:

Consolidated RH SOP	120 of 2015 as amended by 21 of 2017
Balance of Probabilities SOP	121 of 2015

Changes from previous Instruments:

ICD Coding:

ICD-9-CM Codes: 150
ICD-10-AM Codes: C15

Brief description

This is a primary cancer of the food pipe that connects the throat and the stomach.

Confirming the diagnosis

Diagnosis requires confirmation by histology, usually based on a biopsy performed via endoscopy. This will also provide information on the cancer type (adenocarcinoma, squamous carcinoma or other) which is needed to apply some of the SOP factors.

The relevant medical specialist is a gastroenterologist, general surgeon or oncologist.

Additional diagnoses covered by SOP

Adeno-, adenosquamous-, squamous-, poorly differentiated- and undifferentiated-carcinoma of the oesophagus;
Adenoid cystic-, oat cell-, polypoid- and psuedosarcomatous- carcinoma of the oesophagus;
Barrett's adenocarcinoma;
Carcinoma of the oesophagus;
Malignant melanoma of the oesophagus;

Conditions not covered by SOP

Carcinoid tumour of the oesophagus^#
Hodgkin's lymphoma* of the oesophagus
Non-Hodgkin's lymphoma* of the oesophagus
Soft tissue sarcoma* of the oesophagus
Secondary/metastatic cancer/carcinoma involving the oesophagus (code to primary cancer site)

* another SOP applies - the SOP has the same name unless otherwise specified

^# non-SOP condition

Clinical onset

Clinical onset will typically coincide with date of diagnosis. The presence of prior upper gastrointestinal symptoms may not provide a basis for establishing a clinical onset, as a range of other conditions could be responsible. Where other conditions have been excluded then more specific symptoms such as difficulty in swallowing may allow a backdating of clinical onset to a time prior to diagnosis.

Clinical worsening

The only SOP worsening factor is for inability to obtain appropriate clinical management. This condition typically has a poor prognosis. Potential treatments (e.g. surgery) can have high risks and seriously impact quality of life. Treatment with palliative rather than curative intent may be appropriate. Establishing worsening due to inability to obtain appropriate clinical management will require expert medical opinion.

Source URL: https://clik.dva.gov.au/ccps-medical-research-library/statements-principles/m/malignant-neoplasm-oesophagus-b033-c15/rulebase-malignant-neoplasm-oesophagus/pernicious-anaemia

Pipe smoking

Current RMA Instruments:

Consolidated RH SOP	120 of 2015 as amended by 21 of 2017
Balance of Probabilities SOP	121 of 2015

Changes from previous Instruments:

ICD Coding:

ICD-9-CM Codes: 150
ICD-10-AM Codes: C15

Brief description

This is a primary cancer of the food pipe that connects the throat and the stomach.

Confirming the diagnosis

Diagnosis requires confirmation by histology, usually based on a biopsy performed via endoscopy. This will also provide information on the cancer type (adenocarcinoma, squamous carcinoma or other) which is needed to apply some of the SOP factors.

The relevant medical specialist is a gastroenterologist, general surgeon or oncologist.

Additional diagnoses covered by SOP

Adeno-, adenosquamous-, squamous-, poorly differentiated- and undifferentiated-carcinoma of the oesophagus;
Adenoid cystic-, oat cell-, polypoid- and psuedosarcomatous- carcinoma of the oesophagus;
Barrett's adenocarcinoma;
Carcinoma of the oesophagus;
Malignant melanoma of the oesophagus;

Conditions not covered by SOP

Carcinoid tumour of the oesophagus^#
Hodgkin's lymphoma* of the oesophagus
Non-Hodgkin's lymphoma* of the oesophagus
Soft tissue sarcoma* of the oesophagus
Secondary/metastatic cancer/carcinoma involving the oesophagus (code to primary cancer site)

* another SOP applies - the SOP has the same name unless otherwise specified

^# non-SOP condition

Clinical onset

Clinical onset will typically coincide with date of diagnosis. The presence of prior upper gastrointestinal symptoms may not provide a basis for establishing a clinical onset, as a range of other conditions could be responsible. Where other conditions have been excluded then more specific symptoms such as difficulty in swallowing may allow a backdating of clinical onset to a time prior to diagnosis.

Clinical worsening

The only SOP worsening factor is for inability to obtain appropriate clinical management. This condition typically has a poor prognosis. Potential treatments (e.g. surgery) can have high risks and seriously impact quality of life. Treatment with palliative rather than curative intent may be appropriate. Establishing worsening due to inability to obtain appropriate clinical management will require expert medical opinion.

Source URL: https://clik.dva.gov.au/ccps-medical-research-library/statements-principles/m/malignant-neoplasm-oesophagus-b033-c15/rulebase-malignant-neoplasm-oesophagus/pipe-smoking

Plummer-Vinson syndrome

Current RMA Instruments:

Consolidated RH SOP	120 of 2015 as amended by 21 of 2017
Balance of Probabilities SOP	121 of 2015

Changes from previous Instruments:

ICD Coding:

ICD-9-CM Codes: 150
ICD-10-AM Codes: C15

Brief description

This is a primary cancer of the food pipe that connects the throat and the stomach.

Confirming the diagnosis

Diagnosis requires confirmation by histology, usually based on a biopsy performed via endoscopy. This will also provide information on the cancer type (adenocarcinoma, squamous carcinoma or other) which is needed to apply some of the SOP factors.

The relevant medical specialist is a gastroenterologist, general surgeon or oncologist.

Additional diagnoses covered by SOP

Adeno-, adenosquamous-, squamous-, poorly differentiated- and undifferentiated-carcinoma of the oesophagus;
Adenoid cystic-, oat cell-, polypoid- and psuedosarcomatous- carcinoma of the oesophagus;
Barrett's adenocarcinoma;
Carcinoma of the oesophagus;
Malignant melanoma of the oesophagus;

Conditions not covered by SOP

Carcinoid tumour of the oesophagus^#
Hodgkin's lymphoma* of the oesophagus
Non-Hodgkin's lymphoma* of the oesophagus
Soft tissue sarcoma* of the oesophagus
Secondary/metastatic cancer/carcinoma involving the oesophagus (code to primary cancer site)

* another SOP applies - the SOP has the same name unless otherwise specified

^# non-SOP condition

Clinical onset

Clinical onset will typically coincide with date of diagnosis. The presence of prior upper gastrointestinal symptoms may not provide a basis for establishing a clinical onset, as a range of other conditions could be responsible. Where other conditions have been excluded then more specific symptoms such as difficulty in swallowing may allow a backdating of clinical onset to a time prior to diagnosis.

Clinical worsening

The only SOP worsening factor is for inability to obtain appropriate clinical management. This condition typically has a poor prognosis. Potential treatments (e.g. surgery) can have high risks and seriously impact quality of life. Treatment with palliative rather than curative intent may be appropriate. Establishing worsening due to inability to obtain appropriate clinical management will require expert medical opinion.

Source URL: https://clik.dva.gov.au/ccps-medical-research-library/statements-principles/m/malignant-neoplasm-oesophagus-b033-c15/rulebase-malignant-neoplasm-oesophagus/plummer-vinson-syndrome

Smoking tobacco products - material contribution

Current RMA Instruments:

Consolidated RH SOP	120 of 2015 as amended by 21 of 2017
Balance of Probabilities SOP	121 of 2015

Changes from previous Instruments:

ICD Coding:

ICD-9-CM Codes: 150
ICD-10-AM Codes: C15

Brief description

This is a primary cancer of the food pipe that connects the throat and the stomach.

Confirming the diagnosis

Diagnosis requires confirmation by histology, usually based on a biopsy performed via endoscopy. This will also provide information on the cancer type (adenocarcinoma, squamous carcinoma or other) which is needed to apply some of the SOP factors.

The relevant medical specialist is a gastroenterologist, general surgeon or oncologist.

Additional diagnoses covered by SOP

Adeno-, adenosquamous-, squamous-, poorly differentiated- and undifferentiated-carcinoma of the oesophagus;
Adenoid cystic-, oat cell-, polypoid- and psuedosarcomatous- carcinoma of the oesophagus;
Barrett's adenocarcinoma;
Carcinoma of the oesophagus;
Malignant melanoma of the oesophagus;

Conditions not covered by SOP

Carcinoid tumour of the oesophagus^#
Hodgkin's lymphoma* of the oesophagus
Non-Hodgkin's lymphoma* of the oesophagus
Soft tissue sarcoma* of the oesophagus
Secondary/metastatic cancer/carcinoma involving the oesophagus (code to primary cancer site)

* another SOP applies - the SOP has the same name unless otherwise specified

^# non-SOP condition

Clinical onset

Clinical onset will typically coincide with date of diagnosis. The presence of prior upper gastrointestinal symptoms may not provide a basis for establishing a clinical onset, as a range of other conditions could be responsible. Where other conditions have been excluded then more specific symptoms such as difficulty in swallowing may allow a backdating of clinical onset to a time prior to diagnosis.

Clinical worsening

The only SOP worsening factor is for inability to obtain appropriate clinical management. This condition typically has a poor prognosis. Potential treatments (e.g. surgery) can have high risks and seriously impact quality of life. Treatment with palliative rather than curative intent may be appropriate. Establishing worsening due to inability to obtain appropriate clinical management will require expert medical opinion.

Source URL: https://clik.dva.gov.au/ccps-medical-research-library/statements-principles/m/malignant-neoplasm-oesophagus-b033-c15/rulebase-malignant-neoplasm-oesophagus/smoking-tobacco-products-material-contribution

Malignant Neoplasm of the Oesophagus B033

Current RMA Instruments:

Changes from previous Instruments:

ICD Coding:

Brief description

Confirming the diagnosis

Additional diagnoses covered by SOP

Conditions not covered by SOP

Clinical onset

Clinical worsening

Rulebase for malignant neoplasm of the oesophagus

A course of therapeutic radiation to the chest

Current RMA Instruments:

Changes from previous Instruments:

ICD Coding:

Brief description

Confirming the diagnosis

Additional diagnoses covered by SOP

Conditions not covered by SOP

Clinical onset

Clinical worsening

Achalasia

Current RMA Instruments:

Changes from previous Instruments:

ICD Coding:

Brief description

Confirming the diagnosis

Additional diagnoses covered by SOP

Conditions not covered by SOP

Clinical onset

Clinical worsening

Acute erosive oesophagitis as the result of alkali ingestion

Current RMA Instruments:

Changes from previous Instruments:

ICD Coding:

Brief description

Confirming the diagnosis

Additional diagnoses covered by SOP

Conditions not covered by SOP

Clinical onset

Clinical worsening

Alcohol consumption

Current RMA Instruments:

Changes from previous Instruments:

ICD Coding:

Brief description

Confirming the diagnosis

Additional diagnoses covered by SOP

Conditions not covered by SOP

Clinical onset

Clinical worsening

Being obese

Current RMA Instruments:

Changes from previous Instruments:

ICD Coding:

Brief description

Confirming the diagnosis

Additional diagnoses covered by SOP

Conditions not covered by SOP

Clinical onset

Clinical worsening

Cigar smoking

Current RMA Instruments:

Changes from previous Instruments:

ICD Coding:

Brief description

Confirming the diagnosis

Additional diagnoses covered by SOP

Conditions not covered by SOP

Clinical onset

Clinical worsening

Cigarette smoking

Current RMA Instruments:

Changes from previous Instruments:

ICD Coding:

Brief description

Confirming the diagnosis

Additional diagnoses covered by SOP

Conditions not covered by SOP

Clinical onset